Coronavirus Disease 2019 Serial Testing Among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020.
Takaaki Kobayashi, Alexandra Trannel, Stephanie A Holley, Mohammed A Alsuhaibani, Oluchi J Abosi, Kyle E Jenn, Holly Meacham, Lorinda L Sheeler, William Etienne, Angelique Dains, Fernando Casado, Mary E Kukla, Emily K Ward, Bradley Ford, Michael B Edmond, Melanie Wellington, Daniel J Diekema, Jorge L Salinas
Author Information
Takaaki Kobayashi: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA. ORCID
Alexandra Trannel: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Stephanie A Holley: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Mohammed A Alsuhaibani: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Oluchi J Abosi: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Kyle E Jenn: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Holly Meacham: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Lorinda L Sheeler: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
William Etienne: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Angelique Dains: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Fernando Casado: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Mary E Kukla: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Emily K Ward: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Bradley Ford: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Michael B Edmond: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Melanie Wellington: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Daniel J Diekema: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
Jorge L Salinas: 1University of Iowa Hospitals and Clinics, Iowa CIty, Iowa, USA.
We implemented serial coronavirus disease 2019 testing for inpatients with a negative test on admission. The conversion rate (negative to positive) on repeat testing was 1%. We identified patients during their incubation period and hospital-onset cases, rapidly isolated them, and potentially reduced exposures. Serial testing and infectiousness determination were resource intensive.
